Advanced Cancer

Showing NaN - NaN of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Advanced Cancer Trial in Worldwide (Avelumab, Utomilumab, PF-04518600)

Active, not recruiting
  • Advanced Cancer
  • Encinitas, California
  • +87 more
Dec 7, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Advanced Cancer, Metastatic Cancer Trial (Q901)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Phoenix, Arizona
  • +5 more
Sep 1, 2022

Advanced Cancer, End Stage Organ Failure Trial in United States (Nurse-led telephonic case management, Facilitated,outpatient

Active, not recruiting
  • Advanced Cancer
  • End Stage Organ Failure
  • Nurse-led telephonic case management
  • Facilitated,outpatient specialty palliative care
  • Los Angeles, California
  • +17 more
Aug 16, 2022

Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in United States (GNX102)

Recruiting
  • Solid Tumor
  • +3 more
  • Los Angeles, California
  • +5 more
Mar 7, 2022

Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck Trial in United States (FS118)

Recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +6 more
Mar 3, 2022

Advanced Cancer Trial in Worldwide (BMS-986258, Nivolumab, rHuPH20)

Active, not recruiting
  • Advanced Cancer
  • BMS-986258
  • +2 more
  • Los Angeles, California
  • +15 more
Feb 11, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Advance Care Planning, Advance Directives, Advanced Cancer Trial in Irvine, Los Angeles, San Francisco (Advance directive,

Active, not recruiting
  • Advance Care Planning
  • +2 more
  • Advance directive
  • +2 more
  • Irvine, California
  • +2 more
Sep 29, 2021

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

Recruiting
  • Solid Tumor
  • +2 more
  • Los Angeles, California
  • +3 more
Jul 29, 2021

Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)

Terminated
  • Advanced Cancer
  • Mocetinostat - 50 mg
  • +4 more
  • Mobile, Alabama
  • +14 more
Mar 10, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)

Terminated
  • Advanced Cancer
  • Los Angeles, California
  • +17 more
Feb 13, 2018

Advanced Cancer Trial in United States (crizotinib)

Completed
  • Advanced Cancer
  • Los Angeles, California
  • +19 more
Jan 5, 2018

Advanced Cancer Trial in United States (LY2875358, LY2875358 + erlotinib, LY2875358 at Part A highest dose)

Completed
  • Advanced Cancer
  • La Jolla, California
  • +9 more
Feb 14, 2017

Advanced Cancer, Metastatic Solid Tumors Trial in Los Angeles, San Francisco, Cleveland (NKTR-102)

Completed
  • Advanced Cancer
  • Metastatic Solid Tumors
  • Los Angeles, California
  • +2 more
Dec 20, 2016